According to the former Goldman Sachs VP -- who wrote a best-selling book on retirement -- one single stock stands head-and-shoulders above all others. And it should be the cornerstone of your portfolio. Have you heard of it?
|
|
| A special message from our valued partners and today's top market news. | | | |
|
| The A.I. Story Nobody is Telling You (Read ASAP) - Ad
There's been a lot of buzz surrounding A.I. over the past couple of years -- but there's only ONE story you should be worried about. Whether you have $500 or $500,000, this radical new A.I. Innovation will have a direct impact on your wealth. Learn more. | | | | | | Legal Battle Unmasks Shell's Under-The-Radar Oil Trading Earnings: Report
Unveiled in a Texas court, documents from a former employee's lawsuit against Shell PLC expose the financial intricacies of its expansive oil and gas trading arm. Testimony by ex-division head John Dimech sheds light on substantial profits, with annual figures ranging from $950 million to $1 billion. This glimpse into Shell's closely-guarded trading operations highlights its significant contributions to overall U.S. pre-tax profits. Continue Reading ➔ | | | | | | Last Week's Worst-Performing Stocks: Are These 10 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
10 worst performing large-cap stocks last week: LKQ, MSCI, TXT, EDU, BMY, MANH, RS, META, LUV, NUE. Analysts cut price targets for many. Continue Reading ➔ | | | | | | Breaking - AI Drug Sells for $4 Billion - Ad
A Big Pharma giant quietly bought one AI-designed drug for $4 billion designed by a tiny AI-biotech company. Wall Street doesn't yet grasp how this company is quietly revolutionizing the drug discovery business but this won't stay quiet much longer. Continue Reading ➔ | | | | | |
| Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.
339-20 De Boers Dr., Toronto, ON M3J 0H1, 917.672.7040 © 2024 Musth | ActivaTrade | All rights reserved.
Unsubscribe | | | | |
No comments:
Post a Comment